4
Changes in Ownership
Kairos Pharma, LTD. Filed Acc 0001493152-25-029601
Chief Scientific Officer acquired 171,756 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Bhowmick Neil Chief Scientific Officer | 2025-10-08 | Grant or award | +171,756 | 1,311,739 | D |
Loading xslF345X05/ownership.xml…